The salivation-altering medications identified in the present study were angiotensin II receptor blockers, analgesics, anti-infectives, anti-inflammatory medications, alpha-2 agonists, antigout medications, cardiovascular medications like calcium channel blockers, drugs used for diabetes, and those for nicotine dependence, immunosuppressants, and interferons and statins, respectively (Pająk-Łysek et al., 2021; Choo et al., 2022). The gene discussed is PSMA2; the disease is diabetes mellitus.